Raymond James & Associates BELLICUM PHARMACEUTICALS INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 21, 2020
SELL
N/A
-43,734 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
N/A
7,550 Added 20.87%
43,734 $56,000
Q3 2019

Nov 07, 2019
BUY
N/A
5,100 Added 16.41%
36,184 $38,000
Q2 2019

Aug 06, 2019
BUY
N/A
428 Added 1.4%
31,084 $53,000
Q1 2019

May 06, 2019
BUY
N/A
1,149 Added 3.89%
30,656 $103,000
Q4 2018

Feb 11, 2019
BUY
N/A
5,205 Added 21.42%
29,507 $86,000
Q3 2018

Nov 14, 2018
SELL
N/A
-11,150 Reduced 31.45%
24,302 $150,000
Q2 2018

Aug 14, 2018
SELL
N/A
-515 Reduced 1.43%
35,452 $262,000
Q1 2018

May 14, 2018
SELL
N/A
-6,500 Reduced 15.31%
35,967 $236,000
Q4 2017

Feb 14, 2018
SELL
N/A
-12,058 Reduced 22.11%
42,467 $357,000
Q3 2017

Nov 13, 2017
BUY
N/A
18,567 Added 51.64%
54,525 $630,000
Q2 2017

Aug 14, 2017
BUY
N/A
35,958
35,958 $420,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email